Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)

Clinical trial NCT05488132 · UNKNOWN

Trial details

NCT number: NCT05488132
Sponsor: Xuzhou Medical University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia, in Relapse

Start date: 2022-04-01
Primary completion: 2024-03-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.